dual therapy Clinical Trials
2 recruitingDrug
Phase 42
Showing 1–2 of 2 trials
Recruiting
Phase 4
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
HIV Infections
José Antonio Mata Marín156 enrolled1 locationNCT07138144
Recruiting
Phase 4
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
HIV Infection
José Antonio Mata Marín138 enrolled1 locationNCT06907056